It looks to me more and more that "fitx" CEN bio is going to be the cream of the crop in this industry. Seems like most of these companies are winging it, or got a good grower and bad management or vice versa. Tweeds messed up many times already. They have huge money behind them but they will get surpassed by smarter companies quicker then most think. Other companies got great growers and will have great bud but they will lack in the research department in terms of it being medicine, the hows and whys with data to back it up. They will be more so capitalizing on the recreational users in the future. Organic bud will be very important to the marijuana purists. Does anyone know if CEN will be growing any organic strains? Companies like spwrf or whatever the ticker is are kind of a joke. I only heard of them because of the clowns promoting it which in my opinion is a bad look for that company to have such classless idiots pumping them. The industry will be huge and there is plenty of room for many companies to make millions. The market is there, has been for many many many years. Its time for the money to go back into society rather then a black hole. The more I refer back to the audio from the SH meeting February and recall the personal talks I had with Dr.Sam and with Bill... the more I realize they are bang on and have been bang on with every new piece of information comes out. I love the team thats been formed, very real people and very real professionals. Rare for a penny stock in the OTC. I am confident that in time, they will uplist... my guess would be the TSX as they are a little more flexible, just my guess though. But I do think there will be a restructure at some point, sooner then we think too. I really hope Bill keeps his word and get that doing with a buyback. But If he wants to up list quicker then a split of some sort would do the trick instantly. But I won't be surprised if he keeps his word and delivers on it again, he hasn't disappointed yet so... cross my fingers. As a long time player in the industry here in Canada, I truly think FITX will be in the top tier when all said n done. As for the growing patents, I know for a fact that they are not the only company who will be using techniques to get grow cycles done quicker. The doubters laugh at the possibility of that even being realistic and I laugh at the doubters. Like I said, I know its possible but they won't be the only company here that will be growing that fast. I would love to hear some opinions on the re structure....
It looks to me more and more that "fitx" CEN bio is going
Scroll down for more posts ▼
Top 10 Most Recent News Articles
LG OLED evo W6: UAE Roadshow Starts with a Bang
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Hyliion Class Action Deadline Nears for Investors
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue ReadingTop 5 Most Recently Viewed Articles
FDA's NMN Ruling: Naturecan Seizes Opportunities for Growth
FDA's NMN Ruling and Its Significance Naturecan, a prominent global wellness brand, is thrilled by the recent ruling from the U.S. Food and Drug Administration (FDA) regarding ?-Nicotinamide Mononucleotide (NMN). This ruling confirms that NMN is lawful for use in dietary supplements in the United States, paving the way for significant advancements within the global...
Continue Reading
Casepoint Secures Major SEC Contract for Innovative Data Solutions
Casepoint Secures Important Contract Extension with the SEC Casepoint, a leading company in data discovery technology, has successfully extended its contract with the U.S. Securities and Exchange Commission (SEC). This five-year agreement highlights Casepoint's dedication to providing secure, cloud-based solutions designed for regulatory enforcement and compliance in a...
Continue Reading
Intel Corp's Future with Apple: Chip Manufacturing Wins
Intel Corp's Significant Stock Surge Intel Corp (NASDAQ: INTC) saw its stock rise by 7%, thanks to a report signaling the company's exciting potential to produce chips for Apple Inc's upcoming Mac models. Industry analyst Ming-Chi Kuo from TF International Securities provided an optimistic outlook, suggesting Intel is gaining traction in its efforts to expand operations....
Continue Reading
Significant Phase II Breakthrough for Akeso's Ivonescimab in NSCLC
Akeso's Promising Results with Ivonescimab for Lung Cancer Akeso (9926.HK) has recently shared exciting findings from the Phase II study of ivonescimab, a groundbreaking PD-1/VEGF bispecific antibody designed to treat resectable non-small cell lung cancer (NSCLC). This study was highlighted during a key oral session at the 25th World Conference on Lung Cancer (WCLC),...
Continue Reading
Insider Trades at Sherwin-Williams: A Closer Look at Rea's Moves
Recent Insider Trading Activity at Sherwin-Williams Todd Rea, who holds the position of President at Sherwin-Williams (NYSE: SHW), has recently become the center of attention due to his stock option activities. The latest SEC filing reveals that he made a notable decision by exercising options for zero shares of the company’s stock. What This Means for Investors In the...
Continue Reading